The purpose of this paper was to compare diagnostic accuracy among breast specimens obtained by ultrasonography-guided core needle biopsy (US-CNB), ultrasonography -guided vacuum-assisted biopsy (US-VAB), and stereotactic-guided vacuum-assisted biopsy (S-VAB).
Breast Microcalcifications: Diagnostic Outcomes According to Image-Guided Biopsy Method.
Bae S, Yoon JH, Moon HJ, Kim MJ, Kim EK
Purpose
Conclusion
Biopsy failures, false negatives, and a diagnosis of malignancy occurred most frequently in specimens obtained by US-CNB, followed by those obtained by S-VAB then US-VAB. Further, tumors that were sampled by US-CNB were the more likely to receive an upgraded tumor status after surgical resection. Importantly, the method of biopsy depended on the sonographic visibility of calcifications and the presence of a mass; thus, the differences observed between biopsy methods may be attributable to the properties of the tumors sampled.
Studies (1)
Purpose
The purpose of this paper was to compare diagnostic accuracy among breast specimens collected by US-CNB, US-VAB, and S-VAB. US-CNB specimens were obtained with a 14-gauge needle from the breasts of 28 women with a sonographically-visible calcification and an associated mass. US-VAB specimens were obtained with a 8 or 11-gauge vacuum probe from 59 women with sonographically-visible calcification without an associated mass. S-VAB specimens were obtained (unspecified gauge) from 249 women with lesions only visible by mammogram. Proper sampling was confirmed by mammography. A false negative was diagnosed when malignancy was found at a 6, 12 or 24 month follow-up. The mean number of biopsies per lesion was 6.6 with US-CNB, but 12 with US-VAB and 12.6 with S-VAB.
Summary of Findings
Biopsy failure and false negatives for malignancy occurred most frequently in biopsy specimens obtained by US-CNB (2/28 and 3/20 cases, respectively), followed by those obtained by S-VAB (7/249 and 2/46 cases, respectively) and US-VAB (0/59 and 0/31 cases, respectively). After surgical resection, the diagnosis of ductal carcinoma in situ (DCIS) was changed to invasive carcinoma in 5 of 12 (41.7%) US-CNB specimens, but this diagnostic change only occurred in 3 of 35 (8.6%) and 4 of 31 (12.9%) specimens obtained by S-VAB and US-VAB, respectively. Only one diagnosis of atypical ductal hyperplasia (ADH) was changed after surgical resection of a tumor originally biopsied by S-VAB. Importantly, malignancy rates were higher among specimens obtained by US-CNB (83.3%) than by US-VAB (58.5%) or S-VAB (23.7%), but this likely is an artifact of tumor properties influencing guidance method, as biopsies with a sonographically-visible calcification with an associated mass are more likely to be malignant than those without a mass or those only visible by mammography. In addition, malignant tumors sampled by US-CNB were more likely to be classified as invasive carcinomas (9 of 20 cases, respectively), than those sampled by S-VAB (8 of 46 cases, respectively) or US-VAB (5 of 31 cases, respectively).
Biospecimens
TissueBreastPreservation Types
FormalinDiagnoses
NeoplasticBenignNeoplasticCarcinomaNormalPlatforms
MorphologyX-rayMorphologyLight microscopyPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Prognostic factor No ultrasound visible calcificationUltrasound visible calcification and associated massUltrasound visible calcification and no associated massBiospecimen Acquisition Method of tissue acquisition Core needle biopsySterotactic-guided biopsyUltrasound-guided biopsyVacuum assisted biopsy